Hybridon HYBN, for discussion of antisense drugs. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hybridon HYBN, for discussion of antisense drugs.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mounir Abouzakhm who wrote (34)	6/8/1999 11:37:00 PM
From: JMarcus	Read Replies (1) of 42

On Friday John Naples, Controller at HYBN, left me a very prompt and courteous return voice mail (in response to my first ever call to the company), saying "there is no explanation as to why the stock is falling like it is and ended up closing at $0.25. I can tell that everything that the 10Q says, however, is true: we have extended our cash to last through July, and we are currently prudently working in the final stages of a deal. You can call me back if you want, but there really is not a lot that I can tell you." The stock has certainly bounced back since Friday! Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next